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Abstract
Purpose To compare the efficacy and safety of TDR to that
of the fusion for the treatment of lumbar degenerative disc
disease (LDDD).
Methods Randomized controlled trials comparing TDR
with any other intervention for LDDD were acquired by a
comprehensive search in PubMedCentral, MEDLINE,
EMBASE, BIOSIS, ClinicalTrials.gov, and the FDA trials
register. Methodologic quality was assessed and relevant
data were retrieved, and appropriate meta-analysis was
performed. Two review authors independently selected stud-
ies, extracted data, and assessed risk of bias. Results and
upper bounds of confidence intervals were compared with
predefined clinically relevant differences.
Results Six relevant randomized controlled trials (RCTs) in-
volving 1,603 patients were identified and reported two year
follow-up results. Patients in TDR group compared with
lumbar fusion group demonstrated significant improvements
in ODI, VAS scores and complication rates at the two year
follow-up. Meanwhile, except for operating time in anterior
group, intra-operative blood loss, operating time in posterior
group, and reoperation rate were without clinical significance
between the two groups. In addition, the range of motion
(ROM) was maintained within normal ranges after TDR.
Conclusions The results showed the TDR has significant
safety and efficacy comparable to lumbar fusion at two year
follow-up. Although superiority compared to fusion could
not be proved, by comparing clinical symptoms relieved,
motion preserved, and the low reoperation rate during long-
term follow-up on TDR, TDR was considered safe and
effective. Therefore, the authors suggest adopting TDR on
a large scale; with failure of TDR, interbody fusion would
be performed.
Introduction
Lumbar degenerative disc disease (LDDD) is a major cause
of chronic low-back pain with lumbar segmental instability,
in which surgical intervention is required when conservative
treatment fails. Lumbar fusion has been developed for sev-
eral decades as the gold standard for treatment of symptom-
atic LDDD. A mechanically stable fusion of the involved
lumbar segments should reduce pain [1, 2]. However, this
method is not perfect, not only because of complications,
but also because of increasing stress on the adjacent seg-
ments may cause new instability and pain [3–5]. Avariety of
surgical fusion techniques have been performed during the
last century; radiographically confirmed fusion rates have
exceeded 96.7 % [6]. However, all of this has not translated
into an improvement of successful clinical outcomes [7, 8].
This seems to indicate that fusion was not the parameter
which determines the clinical success. In recent years, the
idea of the nonfusion treatment has been gradually accepted
by spine surgeons and the patients, and used in clinical
practice widely.
Artificial total disc replacement (TDR) as an alternative to
spinal fusion has been increasingly applied for surgically
treating LDDD [9, 10]. It was postulated that the patient’s
normal intervertebral segment motion might be restored and
maintained while the adjacent level was prevented from
nonphysiologic loading and thus the pain was relieved
[11–13]. Previous studies that compared the clinical effects
of TDR to fusion for treating LDDD provided ambiguous
results [14–16]. Therefore, it was still uncertain whether
TDR was more effective and safer than fusion. The objective
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of this study was to systematically compare the efficacy and
safety of TDR to fusion for the treatment of LDDD.
Materials and methods
Study selection
All randomized controlled trials comparing TDR with fusion
for the treatment of LDDD were identified. We searched
databases including PubMedCentral, MEDLINE (from
1966), EMBASE(from 1980), BIOSIS (from 2004),
ClinicalTrials.gov, and FDA trials register. The following
sources were searched up to 30 January 2013. The search
strategy consisted of a combination of keywords concerning
the technical procedure (lumbar degenerative disc disease,
lumbar disc replacement, artificial total disc replacement,
lumbar arthroplasty, lumbar fusion, prosthesis, implantation,
and randomized controlled trial) and keywords regarding the
anatomical features and pathology (lumbar vertebrae). These
keywords were used as MESH headings and free text words.
In addition, a search was performed using the specific names
of the prostheses. In this systematic review and meta-analysis,
all of relevant review articles and other potentially eligible
studies were randomized controlled trials (RCTs), the search
was limited to studies published in English. Studies for the
review were randomized controlled trials, published in a peer-
reviewed journal as a full article, excluding grey literature and
conference proceedings.
Two authors (W.J.B. and S.Y.M.) checked all titles and
abstracts from the databases independently which met our
search terms and reviewed full publications, excepted from
this, an authors (L.S.) as a referee independently selected the
articles from the list of identified references whenever nec-
essary. The reference section of all primary studies was
inspected for additional references, and only those reporting
the results of a randomized controlled trial (RCTs) were
included in this analysis. This review was conducted under
the suggested QUORUM guideline standards [17]. If studies
did not report the actual number or the standard deviation,
but rather presented the data only in graph format, the
authors were contacted. Most authors responded but were
not able to provide additional clarification because of per-
sonal circumstances or because the data presented were
preliminary and not available for scientific research. The
main characteristics of the studies included in the meta-
analysis are presented in Table 1.
Data extraction
Two authors (W.J.B. and S.Y.M.) independently extracted
relevant data from the included studies regarding design,
age, gender, type of disc prosthesis, type of fusion
intervention, and follow-up period. The outcomes pooled
in this analysis include visual analogue scale (VAS),
Oswestry disability index (ODI), intra-operative blood loss,
operating time, proportion of full-time and part-time work,
complication, reoperation rate, and the range of motion
(ROM).
Assessment of heterogeneity
The clinical homogeneity related to characteristics of the
participants, including age, sex, clinical manifestation, pain,
function status baseline, and so on. Surgical technique ho-
mogeneity compared the type of artificial lumbar disc and
fusion method, follow-up period, and measurement method.
The chi-squared test was performed to identify the hetero-
geneity, which was directly calculated from the Q statistic
and describes the percentage of variation across the studies
that was due to heterogeneity rather than change.I2 ranges
from 0 to 100 %, with 0 indicating the absence of any
heterogeneity. When I2 was <50 %, low heterogeneity was
assumed, and the effect was thought to be due to change.
Conversely, when I2>50 %, heterogeneity was thought to
exist and the effect was random.
Assessment of risk of bias
Inadequate methodology in randomized controlled trials
leads to the risk of intervention effects overestimation
[18], so assessment of risk of bias in included studies was
necessary. The assessment of bias risk of the included stud-
ies is presented in Table 2. Controlled trials were assessed
using a criteria list recommended by the Cochrane Back
Review Group [19]. The following criteria were scored
yes, no, or unsure: criteria 12 was scored not applicable
because we consider compliance no relevant for surgical
interventions. If studies met at least 6 of the 12 items, it
was considered low.
Statistical analysis
Attempts were made to statistically pool the data of homo-
geneous studies in order to obtain the primary and the
secondary outcomes. According to the recommendations
of the Cochrane Collaboration, the meta-analyses were
using RevMan software (version5.0) provided by the orga-
nization. The results were expressed in terms of odds ratio
(OR) and a 95 % confidence interval (95 % CI) for dichot-
omous outcomes, and in terms of mean difference (MD) and
95 % CI for continuous outcomes. When the same contin-
uous outcomes were measured in different scales, standard-
ized mean difference (SMD) and 95 % CI were calculated. If
in some studies outcomes were shown as dichotomous data
while in the other studies expressed as continuous data, odds
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ratios would be repressed as standardized mean difference to
allow dichotomous and continuous data to be pooled togeth-
er. We performed a sensitivity analysis for the measured
effects omitting the study which may largely influence the
clinical results. If when I2>50 %, only the randomized
effect model was accurate.
Results
The process of identifying relevant studies is summarized in
Table 1. From the selected databases, 382 references were
obtained. By screening the titles and abstracts, 366 refer-
ences were excluded due to the irrelevance to this topic. In
16 potentially relevant references, 10 references were omit-
ted according to conditions listed in Fig. 1. The remaining
16 reports were taken for a comprehensive evaluation.
These reports were based upon six independent continuous
clinical randomized fusion trials, reporting for different
follow-up periods or containing separated results. The six
RCTs with the relevant information were eventually includ-
ed involving 1,603 patients [20–25]. All of these studies
reported two year follow-up results.
Description
The characteristics of six included studies are summarized in
Table 1. In all included studies, the patients with symptomatic
LDDDwere recruited with sample size ranging from 78 to 577
patients. Berg et al. [20]. performed artificial disc replacement
with one of three following devices: CHARITE’, ProDisc-L, or
Maverick (Medtronic, Memphis, TN) compared with the pos-
terolateral fusion (PLF) with autologous bone graft or posterior
interbody fusion (PLIF) with two carbon fiber cages.
Blumethal et al. [21]. performed the CHARITE’ artificial disc
(DePuy Spine, Raynham, MA) replacement compared with
anterior lumbar interbody fusion (ALIF) with BAK cages. In
two studies, the ProDisc-L (Synthes Spine, West Chester, PA)
[22, 23], artificial disc were employed compared with circum-
ferential fusion. Delamarter et al. [24]. reported the prosthesis
consists of two end plates manufactured from cobalt-
chromium-molybdenum (CoCrMo) alloy and a convex ultra-
high molecular weight polyethylene (UHMWPE) insert.
Fixation was provided by a central keel and titanium plasma
spray coating on each end plate. In addition, Gornet et al. [25].
performed the MAVERICK Disc (Medtronic, Memphis, TN)
replacement compared with anterior interbody fusion with
rhBMP-2 on an absorbable collagen sponge (INFUSE Bone
Graft, Medtronic) and tapered fusion cages (LT-CAGE Lumbar
Tapered Fusion Device, Medtronic).
Risk of bias
The outcomes are presented in Table 3. A fixed blocking
method of randomization with six assignments per block
was described in five studies [20–24]. Sealed envelop tech-
nique for allocation concealment was applied in three stud-
ies [20, 22, 23]. In three studies, the participants remained
blinded until the operation was finished. All of the partici-
pants in the six studies had performed the follow-up for at
two years and a follow-up rate of more than 89 % was
obtained in four of these studies [20–23]. None of the
included studies encompassed the information of intention-
to-treat (ITT) analysis. Overall, there trials were classified as
more high methodological quality.
Visual analogue scale. (VAS)
The scales measuring the duration and intensity of pain have
scores ranging from 0 to 10, with a lower score representing
a better condition. The composite back or/and leg pain score
was derived by multiplying the intensity and duration
scores. By this method, the composite score could range
from 0 to 100. At two years, VAS pain scores recorded for
back or/and leg pain indicated statistically significant im-
provement from preoperative levels regardless of treatment.
Only five trials reported the continuous outcome measures
in the form of mean SD, and so they were included in the
meta-analysis [20–24]. They enrolled 1,603 patients, with
1,081 patients assigned to the TDR group and 522 patients
Table 1 Main characteristics of studies included in the meta-analysis
Patients, n Mean Age, y Male, % Type of disk Surgical approaches
(fusion)
Follow-up, y
TDR Fusion TDR Fusion TDR Fusion
Berg et al. [20] 80 72 40.2 38.5 40 42 CHARITE or ProDisc-L, or Maverick posterior 2
Blumenthal et al. [21] 205 99 39.6 39.6 55.1 44.4 CHARITE anterior 2
Delamarter et al. [22] 56 22 39.7 44.2 57 45 ProDisc-L posterior 2
Zigler et al. [23] 161 75 38.7 40.4 50.9 45.3 ProDisc-L posterior 2
Delamarter et al. [24] 174 82 41.8 41.8 57.6 54.2 ProDisc-L posterior 2
Gornet et al. [25] 405 172 39.9 40.2 50 50.6 ProDisc-L anterior 2
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assigned to the fusion group. As for the outcome of VAS
scores, the test for heterogeneity demonstrated that no sig-
nificant heterogeneity existed across the five studies (P=
0.80; I2=0 %), and the fixed model was performed.
Compared with patients treated with fusion, patients treated
with artificial TDR showed a significant decrease (SMD,
−3.18; CI, −5.74 to −0.63; P=0.01) (Figs. 2 and 3). At 2-
year follow-up, the patient functioning ability measured by
VAS in the TDR group was better than that of the fusion
group with statistical significance.
Oswestry disability index(ODI)
The ODI was a validated questionnaire that assesses a patient’s
disability during activities of daily living. ODI success was
defined as 15 % improvement from baseline. Regardless of
Table 2 Criteria for risk of bias assessment
Question Criteria Judgment
1 Was the method of randomization adequate? A random (unpredictable) assignment sequence. Adequate
methods including computer-generated random sequence,
coin toss, rolling a dice, drawing of ballots with the study
group labels from a dark bag, preordered sealed envelops,
and sequentially ordered vials.
Yes/No/Unsure
2 Was the treatment allocation concealed? Adequate if the allocation of patients involved a central
independent unit, on-site locked computer, identically
appearing numbered drug bottles or containers prepared
by an independent pharmacist or investigator, or sealed
envelopes.
Yes/No/Unsure
3 Was the patient blinded to the intervention? The index and fusion groups are indistinguishable for the
patients.
Yes/No/Unsure
4 Was the care provider blinded to the
intervention?
The index and fusion groups are indistinguishable for the
care providers.
Yes/No/Unsure
5 Was the outcome assessor blinded to the
intervention?
For patient-reported outcomes with adequately blinded patients
for outcome criteria that supposes a contact between participants
and outcome assessors: the blinding procedure is adequate if
patients are blinded, and the treatment or adverse effects of the
treatment cannot be noticed during examination for outcome
criteria that do not suppose a contact with participants: the
blinding procedure is adequate if the treatment or adverse effects
of the treatment cannot be noticed during the assessment for
outcome criteria that are clinical or therapeutic events that will
be determined by the interaction between patients and care providers,
in which the care provider is the outcome assessor: the report
needs to be free of selective outcome reporting.
Yes/No/Unsure
6 Was the dropout rate described and acceptable? The number of participants who were included in the study but
did not complete the observation period or were not included
in the analysis are described and reasons are given and are <20 %
or short-term and <30 % for long-term follow-up.
Yes/No/Unsure
7 Were all randomized participants analyses in
the group to which they were allocated?
All randomized patients are reported/analyzed in the group they
were allocated to by randomization for the most important
moments of effect measurement (minus missing values) irrespective
of noncompliance and cointerventions.
Yes/No/Unsure
8 Are reports of the study free of suggestion
of selective outcome reporting?
In general, we expected studies comparing interventions for
low back pain to assess at least pain, Oswestry (or similar)
scores and to evaluate mobility/fusion of the motion segment.
If there were too many studies without these parameters, reporting
bias was suspected, unless confirmed by a full protocol.
Yes/No/Unsure
9 Were the groups similar at baseline regarding
the most important prognostic indicators?
The groups have to be similar at baseline regarding demographic
factors, duration, and severity of complaints, percentage of
patients with neurological symptoms, and value of main
outcome measure(s).
Yes/No/Unsure
10 Were co-interventions avoided or similar? There were no cointerventions or they were similar between the
index and fusion groups.
Yes/No/Unsure
11 Was compliance acceptable in all groups? The compliance with the interventions based on the reported
intensity, duration, number, and frequency of sessions for both
the index intervention and fusion intervention.
Yes/No/Unsure
12 Was the timing of the outcome assessment
similar in all groups?
Timing of outcome assessment was identical for all intervention
groups and for all important outcome assessments.
Yes/No/Unsure
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treatment, all patients showed statistically significant improve-
ment in ODI scores at two year compared with baseline. Six
trials reported the continuous outcome measures as mean
standard deviation(SD), and they were included in the meta-
analysis. Six trials enrolled 1,603 patients, with 1,081 patients
assigned to the TDR group and 522 patients assigned to the
fusion group. The test for heterogeneity demonstrated signifi-
cant heterogeneity existed across the six studies (P=0.88;
I2=0 %), and the random model was performed. The outcome
shown low heterogeneity. Overall, a two year follow-up, the
patient functioning ability measured by ODI in the TDR group
(SMD, −5.13; CI, −7.35 to −2.90; P<0.0001) was better than
that of the fusion group with statistical significance.
Intraoperative blood loss and operating time
Both the intra-operative blood loss and operating time were
reported in five trials [20, 21, 23–25]. Five trials enrolled
1,525 patients with 1,025 patients assigned to the TDR group
and the other 500 patients assigned to the fusion group. The
test for heterogeneity of two groups demonstrated existed
significant heterogeneity(I2=95 %; I2=98 %; respectively).
The greater heterogeneity came from surgery approaches dif-
ferent in fusion group, therefore this trails divided into two
subgroup (e.g., posterior and anterior group) separately based
on surgery approaches different when meta-analysis, and the
randomized effect model was performed. Overall, patients
treated with TDR showed no significant difference no matter
which methods was used compared to patients treated with
fusion in the intra-operative blood loss (SMD, −92.39;
CI, −309.05–124.27; P=0.40 or SMD,70.53; CI,−75.87–
216.94; P=0.35 respectively) (Figs. 4 and 5). Meantime, in
operating time, there were significant difference in anterior
group (SMD, −81.16; CI, −143.60–18.71; P=0.01)(Fig. 6),
while in posterior group, that between TDR and fusion were
no difference(SMD,12.49; CI, −13.85–38.83; P=0.35) (Fig. 7).
Proportion of full-time and part-time work
There were five trails [20, 21, 23–25] reports proportion of
full-time and part-time work. Its enrolled 1,525 patients,
with 1,025 patients assigned to the TDR group and the other
500 patients assigned to the fusion group. The rate was
72.7 % (745 of 1025) in the TDR group and 70.2 % (351
of 500) in the fusion group. The test for heterogeneity
demonstrated that no significant heterogeneity existed
across the five studies (P=0.62; I2=0 %), and the fixed
model was performed. Patients treated with TDR showed a
significant decrease (OR 1.14; 95 % CI [0.89–1.44];
P=0.30) compared to patients treated with fusion (Fig. 6).
382 potentially relevant
16 reports retrieved for more detailed evaluation
10 the full text reports
6 RCTs (7 reports containing useful data) 
366 irrelevant reports excluded
6 non-RCTs reports excluded
4 trials with a less than 2-year follow-up excluded
Fig. 1 Flowchart showing the identification, inclusion, and exclusion
of the randomized controlled trials (RCTs)
Table 3 Risk of bias assessment of included studies












1 Randomization Y Y Y Y Y Y
2 Allocation
Concealment
Y Y Y N Y N
3 Patient Blinding Y N Y N Y Y
4 Surgeon Blinding Y N N N N Y
5 Outcome Blinding N N N N N Y
6 Dropouts Y Y Y Y Y Y
7 Intention to Treat N N N N N N
8 Selective Reporting U U U U U U
9 Baseline Y Y Y Y Y Y
10 Cointerventions Y Y Y Y Y Y
11 Compliance Y Y Y Y Y Y
12 Outcome Timing Y Y Y Y Y Y
Risk of bias 9/12 (low) 7/12 (low) 8/12(low) 6/12 (low) 8/12(low) 9/12 (low)
U unsure, Y yes, N no
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Overall, the patient functioning ability measured by the
proportion of full-time and part-time work in the TDR group
was equivalent to the fusion group follow-up two years.
Complication
Complication including device failures necessitating
reoperation, revision, removal occurred, major vessel injury,
neurologic damage, nerve root injury, death and so on in the
study. The complication rate was reported in five trials
[21–25]. Five trials enrolled 1,525 patients, with 1,025 pa-
tients assigned to the TDR group and the other 500 patients
assigned to the fusion group. The complication rate was 5.8 %
(59 of 1025) in the TDR group and 10.8 % (54 of 500) in the
fusion group. The test for heterogeneity of two studies dem-
onstrated existed significant heterogeneity (P=0.03;
I2=63 %), and the randomized effect model was performed.
Patients treated with TDR showed no significant decrease in
the overall reoperation rate (OR 0.57; 95 % CI [0.38–0.84];
P=0.005) compared with patients treated with fusion (Fig. 7).
Overall, a two year follow-up, the patient functioning ability
measured by complication in the TDR group was better than
that of the fusion group with statistical significance.
Overall reoperation rate
Secondary surgical procedures were defined as any revision,
removal, or reoperation of the implant or supplemental
fixation. The overall reoperation rate was reported in five trials
[20, 22–25]. Five trials enrolled 1,525 patients, with 1,025
patients assigned to the TDR group and 500 patients assigned
to the fusion group. The overall reoperation rate was 5.2% (53
of 1025) in the TDR group and 6 % (30 of 500) in the fusion
group. The test for heterogeneity of two studies demonstrated
existed significant heterogeneity (P=0.07; I2=51 %), and the
randomized effect model was performed. Patients treated with
TDR showed no different in the overall reoperation rate (OR,
0.91; CI, 0.57 to 1.46; P=0.71) compared with patients treated
with fusion (Figs. 8, 9 and 10).
The range of motion (ROM)
Angular motion in the sagittal plane was measured by
comparing lateral flexion and extension radiographs.
Because lacked of the consistent criterion to ROM of lumbar
operation, the five RCTs reports lumbar ROM after treat-
ment of two groups only made common statistical descrip-
tive analysis. By the FDA definition, failures would include
a patient with 7° ROM before surgery at the index level that
maintains 7° at 24 months or a hypermobile segment
returned to a normal functional ROM, and successes would
include improvement from 1° ROM before surgery to a
nonfunctional 2° ROM after surgery. Delamarter et al. [22]
followed up patients at 6 months, and found that difference
of operative segments in L4-5 were statistically significant
while operative segments in L5-S1 was not. Berg et al. [20]
Fig. 2 Results of the meta-analysis for the visual analogue scale (VAS) for TDR and fusion groups at 2-year
Fig. 3 Results of the meta-analysis for the Owestry disability index (ODI) for TDR and fusion groups at 2-year
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reports the ROM of TDR better than the fusion group at
operation level of L4-5 or/and L5-S1, the different of index
mean were not statistically significant compared to pre- and
postoperative after two years, in other words, TDR retained
the normal ranges at operation level. Zigler et al. [23] found
that ROMwas maintained within a normal functional range in
93.7 % of TDR patients at two year follow-up (Delamarter et
al. [24]) reported the ROM in the TDR group averaged 7.8°±
5.3° at the level of the superior disc and 6.2°±4.1° at the level
of the inferior disc at two year. Gornet et al. [25] found at the
TDR group, Compared to the mean angular motion value was
7.0º before surgery, motion varied at 12 and two year were
9.4º and 9.5º respectively, demonstrating not only mainte-
nance but also increase in segmental motion after TDR.
Overall, the range of motion (ROM) was maintained within
normal ranges after TDR, and demonstrated the benefits of




There were five trials [20, 22–25] assessing the safety from
four facets, including intra-operative blood loss, operative
time, surgical complications and the reoperation rate. In
Berg et al. [20], both operation time and hospital stay were
shorter in the TDR group than in the fusion group, but
complications and reoperations were similar in both groups.
Blumenthal et al. [21] reported there was no difference
between the two groups with respect to operative time,
blood loss and complications, but the hospital stay was
significantly shorter in the TDR group. Moreover, he be-
lieved its safety and efficacy would significantly increase
when performed by a skilled surgeon. On the contrary,
Zigler et al. [23] showed that the TDR group was statisti-
cally significantly lower with regard to operative time,
Figs. 4, 5 Results of the meta-analysis for intraoperative blood loss for TDR and fusion subgroups at 2-year
Figs. 6, 7 Results of the meta-analysis for operating time for TDR and fusion subgroups at 2-year
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estimated blood loss, and length of hospital stay. In addition,
retrograde ejaculation was reported in two patients (1.2 %)
in the TDR group, and three patients developed deep venous
thrombosis after surgery (two TDR and one fusion). Gornet
et al. [25] found that the mean operative time was approx-
imately 24 min longer, and a higher blood loss for the TDR
group, which were a statistically significant differences, but
the average lengths of hospital stay for TDR and fusion
patients were similar, and overall adverse event rates
showed no statistical difference. Delamarter et al. [24]
reported intraoperative data showing that operative times,
estimated blood loss, and length of hospital stay were sig-
nificantly decreased in TDR group. Complications included
one dural tear in TDR group (one of 165)and three dural
tears in the fusion group (three of 72). One of the two
patients in TDR group sustained an iliac artery tear, whereas
the other patient in TDR group and the two patients in
fusion group had excessive oozing from the decompression,
decorticated bone, and graft sites. Postoperatively, deep
venous thrombosis was reported in two (1.2 %) of 165
patients in TDR group and two (2.8 %) of 72 in fusion
group. According to meta-analysis results, the intraoperative
blood loss and operating time in the posterior group showed
no significant difference compared to fusion group; apart
from this, operating time in the anterior group and compli-
cations are significantly reduced compared to the fusion
group. Thus, the authors draw a conclusion that safety
in TDR group is better than fusion group at two years
follow-up.
Efficacy
Most of the included studies showed clinically relevant
improvement from VAS, ODI, proportion of full-time and
part-time work, and ROM. In the study of Berg et al. [20],
there were no differences in ODI success; and they were
satisfied with their treatment and full or part-time between
groups at one and two years. He also believed that strictly
choosing surgical indications could improve the efficacy of
the TDR. Blumenthal et al. [21] reported that both the
improvement of ODI and VAS and employment rate had
statistically significant differences favoring the TDR pa-
tients compared to the fusion group at 24 months. Overall
clinical success was significantly higher in TDR group
compared with fusion group. In Zigler et al. [23], except
for SF-36, improvement in ODI, VAS patient satisfaction,
and recreation status had increased, showing a statistically
significant difference favoring the TDR patients compared
to the fusion group at 24 months. Using the FDA definition,
53.4 % of TDR and 40.8 % of fusion patients were success-
ful, with a statistically significant difference favoring the
TDR group. Gornet et al. [25] observed that 24 months
follow-up ODI, a mean improvement of low back pain and
leg pain, and SF-36 scores after surgery were significantly
Fig. 8 Results of the meta-analysis for proportion of full-time and part-time work for TDR and fusion groups at 2-year
Fig. 9 Results of the meta-analysis for complication for TDR and fusion groups at 2-year
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higher than the values for the fusion group. In addition,
the percentage of working participants in the TDR
group was slightly higher than that of the fusion group.
Overall, a significantly higher percentage of TDR pa-
tients showed satisfactory outcomes than fusion patients.
Delamarter et al. [24] reported that the mean improve-
ment of ODI from baseline, the SF-36 score, and VAS
score for patient satisfaction showed a significant differ-
ence in favor of the TDR group at all follow-up time
points. The percentage of patients participating in work
and recreation status had increased in both groups at 24
months, but there was no significant difference between
the TDR group and the fusion group. Wilco C. H.
Jacobs et al. [26] conclude that TDR seems to be
effective in treating low back pain in selected patients,
and in the short term was at least equivalent to fusion
surgery. Berg et al. [20].believed that a strict grasp the
indications for surgery could enhance effectiveness. In
addition, among VAS, ODI, proportion of full-time and
part-time work, meta-analysis results showed statistically
significant improvement compared to fusion group at
24 months. Therefore, it could be said that the efficacy
in the TDR group better than the fusion group.
Deficiency
The trials showed TDR had significant safety and efficacy
compare to fusion at short-term follow-up, but there was a
lack of long-term follow-up, high-quality RCT articles, so
evaluation of the efficacy and safety of TDR comparison of
fusion for the treatment of LDDD was not sufficient. The
current literature reported only long-term follow-up of TDR.
Both medium-term follow-up (from five to ten years)
[27–30] and long-term follow-up (>10 years) [31, 32]
showed significant improvement postoperatively in clinical,
and in radiological the motion preserved in surgical seg-
ment, lower rate of adjacent segment degeneration. No
special complications were noted. In addition, the authors
believe that long-term follow-up should focus on potential
failure of TDR and adjacent segment degenerative.
The potential failures of disc replacement include early
wear, malposition, and prostheses loosening, which are de-
pendent upon numerous factors related to implant design,
surgical technique, and patient-specific factors. This needed
to be revised. Followed up at two years, Blumethal et al.
[21] and Berg et al. [20] reported four (5 %) and five (2.4 %)
patients, respectively, requiring prostheses revision, but
mentioned no surgery method. David [31] reported a mean
follow-up time of 13.2 years, with eight (7.5 %) patients
requiring posterior fusion. In Putzier et al. [32], 6 (11 %) of
patients needed reoperation during a follow-up of 17 years.
The authors believed an organized approach reduced oper-
ative time, minimizes risks, decreases stress, and increases
the success rate. At early failure of surgery TDR prostheses
are removed and revision to another artificial disc can be
considered in order to account for renovated segments with-
out destroying them. Conversely, once renovated sections of
lumbar bone structure have been destroyed, lumbar fusion
must be performed, including posterolateral fusion, 360°
fusion with cages or allograft bone. On the choice of surgi-
cal approaches, Pimenta et al. [33]believed anterior revision
approaches were associated with significant risks due to
scarring and adhesions resulting from the primary proce-
dure, making mobilization of the vessels very difficult,
especially at the L4-5 bifurcation; thus primary revision of
a failed TDR could be planned as a posterior fusion.
With increased age, lumbar disc degeneration result in
lumbar disc space collapse and corresponding stiffening of
spinal segments. It is a normal physiological process. There
are individual differences in this process; thought to be
related to the altered mechanics or loss of motion from the
fusion, adjacent segment degeneration was a controversial
problem that occurred after a spinal fusion. Motion preser-
vation TDR theoretically may decrease or prevent adjacent
segment disease from occurring, but it was difficult to judge
postoperative adjacent disc degeneration, whether from
physiological processes or TDR reasons. In some literature,
follow-up of TDR postoperative more than ten years
reported adjacent segment degenerative disease incidence
of less than 2.8 %, although longer follow-up was not found.
Fig. 10 Results of the meta-analysis for reoperation rate for TDR and fusion groups at 2-year. Abbreviations: TDR, Artificial total disc
replacement; CI, Confidence interval; M-H, Mantel-Haenszel; SD, standard deviation
International Orthopaedics (SICOT) (2013) 37:1315–1325 1323
Despite the lack of comparability, these long-term follow-up
results were encouraging.
The literature holds a positive attitude on the clinical and
radiological in TDR long-term follow-up. Despite lacking of
fusion group comparison, TDR was found to be at least as
safe and effective as a treatment of LDDD.
Limitation
Meta-analysis is a statistical analysis of data collected from
several different researches and surveys on the same prob-
lem, pooling outcomes in order to arrive at a more unbiased
and scientific conclusion [34, 35]. The purpose of this study
is to systematically compare the efficacy and the safety of
TDR to fusion for the treatment of LDDD. In this meta-
analysis, although we identified six RCTs, and five of six
trails were regarded as high-quality, the results still have
limited application because there exist some problems. First
of all was the methodologic quality. In these trials, two
studies [23, 25] had no allocation concealment. Some
scholars [36] believe that allocation concealment, rather
than a perfect test and a non-hidden distribution plan or
distribution plan to hide imperfections test, often exagger-
ated treatment effect of 30−41 %. It may produce measure-
ment bias that patient blinded in two trails [21, 23] and
surgeon blinded in three trails [21–23] to the intervention.
In addition to this, the literature of Zigler et al. [23] used
allocation concealment, patient blinded and surgeon blinded
at the same time,and thus was a relatively high-bias risk
trial. Overall, their trials were classified as of higher meth-
odological quality. Secondly, results are affected by hetero-
geneity caused by random sampling. For example, the
results of the intra-operative blood loss and operating time
presented significant heterogeneity. Third, these literature
are adopted to different models of artificial disc and differ-
ent interventions, and thus there may implement bias.
Fourth, most of the retrieved documents were English; there
may be language bias. Results of these trials tend to report
the superior efficacy of lumbar disc replacement, so the
system studies have higher risk of publication bias.
Conclusion
The results showed the TDR has significant safety and
efficacy, comparable to lumbar fusion at two year follow-
up. Although the superiority compared to fusion could not
be proved, becasuse clinical symptoms were relieved, mo-
tion preserved, and a low reoperation rate during long-term
follow-up on TDR, TDR was considered safe and effective.
Therefore, authors suggest adoption of TDR on a large
scale; once there is failure of TDR, interbody fusion could
be performed.
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